 |
|
Mayo Clinic Proceedings: Men with chronic heart failure can have active sex lives
October 05, 2007ROCHESTER, Minn. -- Although medication can help extend the lives of men with chronic heart failure, several factors associated with this disease can interfere with a person's ability to engage in and enjoy sexual activities. Fatigue, depression, medication side effects and the fear of damaging the heart can cause people with chronic heart failure to lose interest in sex or wonder whether this activity is safe for them.
A literature review published in the October issue of Mayo Clinic Proceedings finds that with proper screening and treatment, many patients with chronic heart failure can safely engage in sexual activity.
Methods
Co-authors Stacy Mandras, M.D., Patricia Uber, Pharm. D., and Mandeep Mehra, M.D., conducted systematic independent literature searches using the MEDLINE database and examined a broad range of medical research that focused on chronic heart failure, sexual activity and sexual dysfunction. This literature included data from patient surveys and clinical trials.
Findings
Many people with chronic heart failure worry that having sex will place too great a strain on the heart. To address this issue, Drs. Mandras and Mehra analyzed studies that showed the impact of sexual activity on heart rate, blood pressure and respiratory rates, which typically increase during sexual activity and other forms of exertion.
One study the authors reviewed measured these changes in middle-aged men with and without coronary artery disease. This study found that the peak heart rate during intercourse was lower than heart rates measured during the patients' normal daily activities. The study participants' peak oxygen consumption levels during intercourse were moderate - comparable to their oxygen consumption levels during moderate activities such as walking on level ground at 3 to 4 miles per hour, climbing stairs slowly or doing general housework such as vacuuming.
The authors also addressed how to counsel and treat chronic heart failure patients who are coping with erectile dysfunction, difficulty achieving or maintaining an erection. Researchers estimate that erectile dysfunction affects 60 percent to 70 percent of people who have chronic heart failure.
The authors observe that multiple factors may be involved. In addition to decreased exercise capacity, patients with chronic heart failure have blood vessel and circulation abnormalities that can reduce blood flow into the penis and interfere with the ability to maintain an erection. And erectile dysfunction can be caused or worsened by many of the medications that are commonly prescribed to treat chronic heart failure.
Currently, the preferred treatment for erectile dysfunction includes sildenafil (Viagra), vardenafil (Levitra) and tadalafil (Cialis). However, numerous experts have raised concerns about the use of these drugs in patients with chronic heart failure who also take nitrates (or other medications that relax and widen blood vessels). This drug combination has been shown to be dangerous, because it can increase the risk for a life-threatening drop in blood pressure.
To further explore this potential risk, the authors reviewed results from a variety of studies in which male patients with congestive heart failure took sildenafil. The authors observed that more data are needed to determine the safety of the newer drugs, vardenafil and tadalafil, for these patients.
"Taken together, these studies show that erectile dysfunction in patients with mild to moderate chronic heart failure can be safely and effectively treated with sildenafil, provided that patients are appropriately screened before therapy," say the authors.
For those patients who cannot take erectile dysfunction medications, the authors counsel that an exercise training regimen may be an appropriate substitute therapy to enhance sexual function and quality of life. The authors stress that clinicians should focus on the sexual activity history of chronic heart failure patients and not ignore it, since addressing this element can substantially improve their quality of life.
Mayo Clinic
Co-authors Stacy Mandras, M.D., Patricia Uber, Pharm. D., and Mandeep Mehra, M.D., conducted systematic independent literature searches using the MEDLINE database and examined a broad range of medical research that focused on chronic heart failure, sexual activity and sexual dysfunction. This literature included data from patient surveys and clinical trials.
Findings
Many people with chronic heart failure worry that having sex will place too great a strain on the heart. To address this issue, Drs. Mandras and Mehra analyzed studies that showed the impact of sexual activity on heart rate, blood pressure and respiratory rates, which typically increase during sexual activity and other forms of exertion.
One study the authors reviewed measured these changes in middle-aged men with and without coronary artery disease. This study found that the peak heart rate during intercourse was lower than heart rates measured during the patients' normal daily activities. The study participants' peak oxygen consumption levels during intercourse were moderate - comparable to their oxygen consumption levels during moderate activities such as walking on level ground at 3 to 4 miles per hour, climbing stairs slowly or doing general housework such as vacuuming.
The authors also addressed how to counsel and treat chronic heart failure patients who are coping with erectile dysfunction, difficulty achieving or maintaining an erection. Researchers estimate that erectile dysfunction affects 60 percent to 70 percent of people who have chronic heart failure.
The authors observe that multiple factors may be involved. In addition to decreased exercise capacity, patients with chronic heart failure have blood vessel and circulation abnormalities that can reduce blood flow into the penis and interfere with the ability to maintain an erection. And erectile dysfunction can be caused or worsened by many of the medications that are commonly prescribed to treat chronic heart failure.
Currently, the preferred treatment for erectile dysfunction includes sildenafil (Viagra), vardenafil (Levitra) and tadalafil (Cialis). However, numerous experts have raised concerns about the use of these drugs in patients with chronic heart failure who also take nitrates (or other medications that relax and widen blood vessels). This drug combination has been shown to be dangerous, because it can increase the risk for a life-threatening drop in blood pressure.
To further explore this potential risk, the authors reviewed results from a variety of studies in which male patients with congestive heart failure took sildenafil. The authors observed that more data are needed to determine the safety of the newer drugs, vardenafil and tadalafil, for these patients.
"Taken together, these studies show that erectile dysfunction in patients with mild to moderate chronic heart failure can be safely and effectively treated with sildenafil, provided that patients are appropriately screened before therapy," say the authors.
For those patients who cannot take erectile dysfunction medications, the authors counsel that an exercise training regimen may be an appropriate substitute therapy to enhance sexual function and quality of life. The authors stress that clinicians should focus on the sexual activity history of chronic heart failure patients and not ignore it, since addressing this element can substantially improve their quality of life.
Mayo Clinic
Heart Failure News and Current Heart Failure Events RSSComputed tomography provides anatomy -- we need ischemia!
Cardiac computed tomography has revolutionized cardiac imaging in recent years by providing exquisitely detailed cardiac anatomy, including, but not limited to, coronary anatomy.
Class of diabetes drugs carries significant cardiovascular risks
A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members.
Air pollution damages more than lungs: Heart and blood vessels suffer too
As athletes from around the world compete in the Beijing Olympics, many are on alert for respiratory problems caused by air pollution. They should also be concerned about its toxic effects on the heart and cardiovascular system, mounting research shows.
Large reservoir of mitochondrial DNA mutations identified in humans
Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population.
Cardiac resynchromization: Race, age, geography matter, study shows
Race, age, and geography appear to play important roles in who receives cardiac resynchronization therapy (CRT), a proven treatment for some patients with heart failure, say researchers at Duke Clinical Research Institute (DCRI).
Want a reason to love your lower belly fat? It's rich in stem cells
Fat removed from the lower abdomen and inner thigh through liposuction was found to be an excellent source of stem cells, with higher stem cell concentrations than other areas of the body.
Exercise could be the heart's fountain of youth
Absence may make the heart grow fonder, but endurance exercise seems to make it younger. According to a study conducted at Washington University School of Medicine in St. Louis, older people who did endurance exercise training for about a year ended up with metabolically much younger hearts.
New Guidelines for Treating Rheumatoid Arthritis
Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB).
Certain anticancer agents could be harmful to patients with heart disease
A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis.
New source of heart stem cells discovered
Researchers at Children's Hospital Boston are continuing to document the heart's earliest origins. Now, they have pinpointed a new, previously unrecognized group of stem cells that give rise to cardiomyocytes, or heart muscle cells.
More Heart Failure News Articles
 | Miracle Stem Cell Heart Repair: (For Heart Attack, Heart Failure and Bypass Patients) by Christian Wilde |
 | Success With Heart Failure: Help and Hope for Those with Congestive Heart Failure by Marc Silver This new and improved edition of Success With Heart Failure gives readers enlightened and compassionate insight and important tips for treating this prevalent disease, including information on:--The similarities and differences between heart failure and heart attack--The role of heart transplantation to treat heart failure--State-of-the-art implantation treatments--The psychological effect of a... |
 | Death by Deception: Unmasking Heart Failure by Dick Quinn, Shannon Quinn, Colin Quinn, Al Watson |
 | Diastology: Clinical Approach to Diastolic Heart Failure by Allan L. Klein, Mario J. Garcia This reference thoroughly equips you to successfully diagnose and manage even the most complex incidences of diastolic heart failure and their comorbidities. It examines the basic mechanisms of this condition through discussions of both cellular and anatomic causes; guides you through non-invasive techniques for diagnosis, including echocardiography, cardiac CT, and MRI; and provides expert... |
 | Heart Failure: A Cleveland Clinic Guide (Cleveland Clinic Guides) by Randall Starling, M D Starling Fifteen to 20 years ago, physicians more or less treated everybody the same way with two or three pills, and that's all they had to offer. The clock was ticking while doctors waited until patients were so sick they needed heart transplants. The medical landscape is completely different today. Now doctors methodically dissect cases of heart failure; they figure out the underlying issues. It's... |
 | 100 Questions & Answers About Congestive Heart Failure (100 Questions & Answers about . . .) by Campion Quinn This book provides readers with authoritative, practical answers to questions about congestive heart failure, including causes, diagnosis, treatment options, quality of life, care giving, sources of support, and much... |
 | MemoCharts Pharmacology: Drug Therapy for Congestive Heart Failure (Review chart) by Howard Shen |
 | Comprehensive Intraaortic Balloon Counterpulsation by Susan J. Quaal The only book of its kind on the market, COMPREHENSIVE INTRA-AORTIC BALLOON PUMPING covers the basic principles, indications, and contraindications of intra-aortic balloon pumping (IABP) for the critical care nurse. This comprehensive text provides a complete reference on all aspects of balloon pumping and patient care, offering an in-depth overview of this method of circulatory assistance as... |
 | The Nuts and Bolts of Cardiac Resynchronization Therapy (Nuts and Bolts Series) by Tom Kenny The Nuts and Bolts of Cardiac Resynchronization TherapyBy Tom Kenny, RNVice President, Clinical Education and Training, St. Jude Medical, Austin, TX, USACardiac resynchronization therapy (CRT) is an exciting new option for a growing number of heart failure patients, but CRT systems present special challenges to clinicians, even those accustomed to working with pacemakers. Now, Tom Kenny... |
 | Resynchronization and Defibrillation for Heart Failure: A Practical Approach by David L. Hayes, Paul J. Wang, Jonathan Sackner-Bernstein, Samuel J. Asirvatham Resynchronization and Defibrillation for Heart Failure: A Practical Approach is one of the first texts to provide caregivers with information about the background and application of this new and rapidly expanding discipline. Its four authors are cardiologists who have expertise in device management, electrophysiology, and heart failure management. The text integrates the approach and management... |
| © 2008 BrightSurf.com |